Schmieg Resigns as CFO of Sirna; Venuti Moves from Celera to Discovery Partners; Evans to be CEO of OGT; Brenner Wins Life Science Achievement Award; and others | GenomeWeb

Martin Schmieg has resigned as senior vice president and CFO of Sirna Therapeutics for personal and family reasons, effective April 22, the Boulder, Colo-based said last week. He will continue to help the company during a transition period after hiring a new CFO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.